Lichenoid Dermatitis: Causes, Symptoms, and Treatments

Lichenoid dermatitis is a distinctive inflammatory skin condition characterized by purple, itchy bumps that often resemble lichen planus. This condition can be triggered by various factors, including medications, infections, and systemic diseases. Understanding the underlying causes, recognizing the symptoms, and seeking appropriate treatment are crucial for managing this chronic skin disorder.

The term "lichenoid" refers to the flat-topped, polygonal papules that resemble lichen on rocks. These bumps are typically purple or violaceous and can appear on any part of the body, often accompanied by intense itching. This disorder can be idiopathic or secondary to known triggers, with drug-induced cases being particularly common.

What Is Lichenoid Dermatitis?

This disorder is a histopathological pattern of skin inflammation that mimics lichen planus. Under the microscope, it shows a band-like lymphocytic infiltrate in the upper dermis, with damage to the basal layer of the epidermis. Clinically, it presents as pruritic, violaceous papules and plaques that can be widespread or localized.

It is not contagious but can significantly impact quality of life due to chronic itching and cosmetic concerns. Early diagnosis and identification of triggers are essential for effective management.

Symptoms of Lichenoid Dermatitis

The hallmark of this condition is the presence of purple, flat-topped, itchy bumps. These lesions often have a shiny surface and may have white lines (Wickham striae) on their surface. Common symptoms include:

• Purple papules – flat-topped, polygonal bumps ranging from 1-10 mm in diameter.
• Intense itching – often worse at night or with stress.
• Scaling and crusting – due to scratching.
• Hyperpigmentation – residual dark spots after lesions resolve.

Lesions can appear on the wrists, ankles, lower back, genitals, and mucous membranes. In drug-induced cases, the eruption may be more widespread and intense.

Drug Causes of Lichenoid Dermatitis

One of the most common triggers of this inflammatory condition is medications. Drug-induced lichenoid dermatitis can occur weeks to months after starting a new drug. Common culprits include:

• Antimalarials – such as hydroxychloroquine.
• Beta-blockers – like propranolol.
• ACE inhibitors – e.g., lisinopril.
• NSAIDs – including ibuprofen.
• Gold salts – used in rheumatoid arthritis.
• TNF-alpha inhibitors – biologics like infliximab.

Drug-induced lichenoid dermatitis typically resolves upon discontinuation of the offending agent, but it may take several weeks to months for the skin to clear completely. Patch testing and drug provocation tests can help identify the cause.

Other Causes and Risk Factors

Besides drugs, this condition can be triggered by:

• Infections – Hepatitis C virus, HIV, and herpes zoster.
• Systemic diseases – Lupus erythematosus, graft-versus-host disease.
• Autoimmune conditions – Alopecia areata, vitiligo.
• Contact allergens – Metals like gold, mercury, and dental amalgam.
• Physical factors – Trauma, sun exposure (Koebner phenomenon).

Genetic predisposition may play a role, as familial cases have been reported. Stress and emotional factors can exacerbate itching.

Diagnosis

Diagnosis of this disorder relies on clinical examination and skin biopsy. A dermatologist will assess the appearance, distribution, and history of the rash. Biopsy reveals characteristic histology: a band-like lymphocytic infiltrate at the dermo-epidermal junction, vacuolar degeneration of basal keratinocytes, and colloid bodies. Direct immunofluorescence may be used to rule out lupus erythematosus.

Blood tests may help identify underlying infections (e.g., hepatitis C) or autoimmune markers. Patch testing can detect contact hypersensitivity to metals or other allergens.

Treatment Options

Treatment focuses on alleviating itching, reducing inflammation, and eliminating triggers. Options include:

• Topical corticosteroids – first-line therapy for localized lesions.
• Topical calcineurin inhibitors – tacrolimus or pimecrolimus for sensitive areas.
• Oral antihistamines – to control itching.
• Phototherapy – narrowband UVB for widespread disease.
• Systemic corticosteroids – short-term use for severe flares.
• Immunosuppressants – methotrexate, azathioprine, or mycophenolate mofetil in refractory cases.

For drug-induced cases, withdrawal of the causative medication is essential. Patients should avoid sun exposure and use sunscreen, as photosensitivity can worsen the rash. Emollients and gentle skin care help reduce irritation.

Prognosis

The course of this condition varies. Idiopathic cases may persist for years with intermittent flares. Drug-induced cases usually resolve within weeks to months after stopping the drug, but post-inflammatory hyperpigmentation can last for months. Early treatment improves outcomes and reduces scarring. Regular follow-up with a dermatologist is recommended to monitor for recurrences or complications.

Prevention Strategies

Preventing this condition involves avoiding known triggers. For drug-induced lichenoid dermatitis, careful medication history and alternatives can be discussed with your doctor. Avoid contact with allergenic metals (e.g., gold, nickel). Manage stress through relaxation techniques, and protect skin from trauma and excessive sun exposure.

When to See a Doctor

Seek medical evaluation if you develop persistent purple, itchy bumps that do not resolve with over-the-counter treatments. A dermatologist can provide a definitive diagnosis and rule out other conditions. If you suspect a medication is causing the rash, do not stop without professional guidance.

Living with this condition can be challenging, but with proper management, most patients achieve significant symptom relief. Stay informed, adhere to treatment, and communicate openly with your healthcare provider.